Arcturus Therapeutics Holdings Inc. (ARCT)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
We’re sorry, we weren’t able to find any data.
Please try reloading the page.
Trading Information
Stock Price History
| Beta (5Y Monthly) | 2.74 |
| 52-Week Change 3 | N/A |
| S&P500 52-Week Change 3 | N/A |
| 52 Week High 3 | 65.00 |
| 52 Week Low 3 | 12.12 |
| 50-Day Moving Average 3 | 22.93 |
| 200-Day Moving Average 3 | 35.48 |
Share Statistics
| Avg Vol (3 month) 3 | 655.07k |
| Avg Vol (10 day) 3 | 733.61k |
| Shares Outstanding 5 | 26.36M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 22.71M |
| % Held by Insiders 1 | 13.90% |
| % Held by Institutions 1 | 76.83% |
| Shares Short (Apr 28, 2022) 4 | 3.05M |
| Short Ratio (Apr 28, 2022) 4 | 4.21 |
| Short % of Float (Apr 28, 2022) 4 | 17.92% |
| Short % of Shares Outstanding (Apr 28, 2022) 4 | 11.55% |
| Shares Short (prior month Mar 30, 2022) 4 | 2.59M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Nov 15, 2017 |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:7 |
| Last Split Date 3 | Nov 15, 2017 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 30, 2021 |
| Most Recent Quarter (mrq) | Dec 30, 2021 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | -1,641.33% |
Management Effectiveness
| Return on Assets (ttm) | -29.17% |
| Return on Equity (ttm) | -65.20% |
Income Statement
| Revenue (ttm) | 12.36M |
| Revenue Per Share (ttm) | 0.47 |
| Quarterly Revenue Growth (yoy) | 158.90% |
| Gross Profit (ttm) | 12.36M |
| EBITDA | -201.66M |
| Net Income Avi to Common (ttm) | -203.67M |
| Diluted EPS (ttm) | -7.55 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 370.49M |
| Total Cash Per Share (mrq) | 14.05 |
| Total Debt (mrq) | 69.15M |
| Total Debt/Equity (mrq) | 30.30 |
| Current Ratio (mrq) | 3.81 |
| Book Value Per Share (mrq) | 9.83 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -135.04M |
| Levered Free Cash Flow (ttm) | -76.44M |
